Amadou Diarra brings over three decades of global expertise in healthcare innovation, P&L management, market access, policy, government affairs, patient advocacy, philanthropy, and strategic governance. His career spans executive and board leadership, with a track record of delivering sustainable growth and leading policy-driven transformation, underscored by a commitment to health equity. Known for his ability to navigate complex stakeholder environments and advance pharmaceutical innovation, Amadou offers public and private boards a distinctive perspective at the intersection of healthcare policy, commercialization and governance, with a focus on long-term strategic value creation.

Amadou’s journey at Bristol-Myers Squibb (BMS) began in 1991, where he steadily rose through positions of increasing responsibility, navigating complex market environments, successfully launching new initiatives/products, and driving significant business growth. Early in his career, Amadou held several general management roles for Indonesia, Turkey, the Nordics, UK & Ireland. As VP-Market Access Europe, he held responsibility over pricing & reimbursement, government affairs and brand communications. Separately he also led a $115M landmark philanthropic initiative to combat HIV/AIDS in Africa.

Most recently, as Senior Vice President of Global Policy, Advocacy, and Government Affairs, Amadou spearheaded BMS’ efforts to create a pro-patient and pro-innovation environment on a global scale. He led an integrated organization that engaged with key stakeholders, including policymakers, patient support organizations, healthcare professionals, and industry associations. Amadou’s leadership was instrumental to successfully influence major healthcare reforms and establish platforms that have significantly enhanced the equity, efficiency and sustainability of healthcare delivery worldwide.

Amadou’s leadership is further reflected in the roles he held as Chair of PhRMA’s International Section Executive Committee, Board Chair of BioNJ, Council Chair of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and member of the U.S. Chamber Board of Directors. Amadou is now Finance Committee Chair of The Max Foundation Board, Member of the Hypertrophic Cardiomyopathy Association (HCMA) Board, Member of Friends of The Global Fight Against AIDS, TB and Malaria Board and Advisor to the BioNJ Board. Amadou was recently appointed a Fellow of the New York Academy of Medicine.

Amadou holds a Doctorate in Pharmaceutical Science from the University of Tours and an MBA in Management from Ecole Supérieure de Commerce de Tours. He completed the General Management Program at INSEAD CEDEP and is a member of the Executive Leadership Council. To board service, Amadou offers the NACD Directorship Certification®.